Association between systemic microvascular dysfunction and resistant hypertension: Insights from a clinical
Vinicius Crahim1, Valéria Verri1, Andrea De Lorenzo1
1National Institute of Cardiology, Rio de Janeiro, Brazil.
Microvascular Research
|March 15, 2026
Summary
Resistant arterial hypertension (RAH) shows significant systemic microvascular impairment affecting endothelial function and structure. Non-resistant arterial hypertension (NRAH) also exhibits microvascular dysfunction compared to healthy controls.
Area of Science:
- Cardiovascular Science
- Hypertension Research
- Microvascular Physiology
Background:
- Resistant arterial hypertension (RAH) is linked to high cardiovascular risk, potentially due to systemic microvascular dysfunction.
- While non-resistant arterial hypertension (NRAH) shows early endothelial impairment, direct microvascular comparisons across RAH, NRAH, and controls are limited.
Purpose of the Study:
- To compare systemic microvascular function in patients with RAH, NRAH, and normotensive individuals.
- Utilize laser speckle contrast imaging to assess microvascular reactivity.
Main Methods:
- Assessed microvascular reactivity using acetylcholine (ACh) and sodium nitroprusside (SNP) iontophoresis, and post-occlusive reactive hyperemia (PORH).
- Compared baseline microvascular conductance, vasodilation responses (AUCs for ACh and SNP), and PORH parameters via one-way ANOVA.
Main Results:
- Baseline microvascular conductance was higher in controls than hypertensive groups.
- Endothelium-dependent vasodilation (ACh AUC) and endothelium-independent vasodilation (SNP AUC) were progressively impaired from controls to NRAH to RAH.
- RAH showed reduced peak microvascular conductance and smaller delta values during PORH, indicating structural arteriolar issues.
Conclusions:
- RAH is characterized by significant systemic microvascular impairment impacting endothelial function and vascular structure.
- These microvascular alterations in RAH coexist with metabolic and renal disorders.
- Complex interactions between vascular, metabolic, and renal factors contribute to treatment-resistant hypertension.
Related Concept Videos
Hypertension II: Pathophysiology
1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Vascular Resistance
12.5K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
12.5K
Hypertension and Regulation of Blood Pressure
4.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Hypertension III: Clinical Manifestations and Diagnostic Studies
703
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
703
Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Hypertension I: Introduction
1.1K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.1K


